Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
(OB: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
All news about
 
< Previous 1 2 Next >
Two Biotech Ideas You May Have Missed: William Gregozeski
May 16, 2013
Two Biotech Ideas You May Have Missed: William Gregozeski Source: George S. Mack of The Life Sciences Report (5/16/13) http://www.thelifesciencesreport.com/pub/na/15278 Adventurous investors have long... Read More
category BTI , AHRO , The Life Sciences Report
from Bio-Wire.Com
Finding the Next Big Blockbuster Drug
May 15, 2013
from ACCESSWIRE
AtheroNova Announces Approval for Phase 1 by the Russian Ministry of Healthcare with Commencement of Human Trials Imminent
May 09, 2013
Russian Licensing Partner Notified of Protocol Approval Read More
from PR Newswire
Noted Atherosclerosis Researcher Joins AtheroNova Team
April 17, 2013
Dr. John Kastelein Appointed Co-Principal Investigator Read More
from PR Newswire
It’s Time to Re-Think the Clinical Approach to Battle Cholesterol and Atherosclerosis
April 17, 2013
from ACCESSWIRE
/C O R R E C T I O N -- AtheroNova Inc./
April 15, 2013
from PR Newswire
AtheroNova Adds New Medical Advisor
April 15, 2013
Dr. John Kastelein Appointed Co-Principal Investigator Read More
from PR Newswire
AtheroNova Adds New Medical Advisor
April 11, 2013
Dr. Stephen Nicholls named as Chair of Clinical Advisory Board Read More
from PR Newswire
AtheroNova Announces Shareholder Realignment
March 14, 2013
from PR Newswire
Atherosclerosis and the New Gold Standard
February 25, 2013
from ACCESSWIRE
AtheroNova Launches New Website
January 29, 2013
from Marketwired News Releases
AtheroNova to Present at Noble Financial Capital Markets' Ninth Annual Equity Conference
January 17, 2013
from PR Newswire
Noble Financial January 22-23 Equity Conference Attracts More Than 100 Public Companies
January 11, 2013
from Marketwired News Releases
AtheroNova Names New Clinical Affairs Officer
January 08, 2013
Joan Shaw Named to Clinical Post Read More
from PR Newswire
AtheroNova Names New Chief Medical Officer
December 18, 2012
Dr. Mark Wedel Named to Senior Post Read More
from PR Newswire
AtheroNova Names New Chief Medical Officer
December 18, 2012
Dr. Mark Wedel Named to Senior Post Read More
from PR Newswire
AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383
November 15, 2012
Dissolution of Arterial Plaque Using Hyodeoxycholic Acid Read More
from PR Newswire
AtheroNova Announces Milestone Filing of IND in Russian Federation
November 13, 2012
Licensing Partner formally applies to the Ministry of Healthcare Read More
from PR Newswire
AtheroNova Names New Director
November 07, 2012
Fred Knoll of Knoll Capital Management Joins the Board of Directors Read More
from PR Newswire
AtheroNova Completes $2.9 Million Private Placement of Common Stock
October 11, 2012
Provides Runway Through Phase I & II Clinical Trials Read More
from PR Newswire
Additional Study to Commence at The David Geffen School of Medicine at the University of California Los Angeles (UCLA)
October 09, 2012
from PR Newswire
AtheroNova to Present at the 2012 Aegis Healthcare Conference in Las Vegas
September 25, 2012
from PR Newswire
AtheroNova to Present at Rodman & Renshaw 14th Annual Healthcare Conference in New York City
September 05, 2012
from PR Newswire
AtheroNova Receives Notice of Allowance for Its US Patent Application 12/024,908
July 09, 2012
Dissolution of Arterial Plaque Using Hyodeoxycholic Acid Read More
from PR Newswire
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on AtheroNova Inc.
June 06, 2012
from Marketwired News Releases
AtheroNova Signs Agreement for Development of Clinical Trial Supplies
April 25, 2012
Formulation Developer Now Working with First Clinical Compounding Project Read More
from PR Newswire
AtheroNova Releases 2011 Financial Results
March 21, 2012
-Company Remains On Track With Development Activities- Read More
from PR Newswire
AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001
March 01, 2012
First Clinical Grade Product Ships to CardioNova in Advance of Toxicology Studies Read More
from PR Newswire
Maxwell Biotech Venture Fund Officially Opens its Office in Boston
February 23, 2012
from Business Wire News Releases
AtheroNova Announces a New Board Member
January 05, 2012
from PR Newswire
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here